中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2014年
23期
3540-3542
,共3页
多发性骨髓瘤%骨髓瘤骨病%巨噬细胞炎症蛋白-1α%骨硬化蛋白
多髮性骨髓瘤%骨髓瘤骨病%巨噬細胞炎癥蛋白-1α%骨硬化蛋白
다발성골수류%골수류골병%거서세포염증단백-1α%골경화단백
Multiple myeloma%Multiple myeloma bone disease%Macrophage inflammatory protein 1-α%Sclerostin
目的:研究巨噬细胞炎症蛋白-1α( MIP-1α)、骨硬化蛋白与多发性骨髓瘤( MM)并发骨髓瘤骨病( MBD)的关系。方法以52例MM患者为观察组,其中无骨病者9例,有骨病者43例;MBD分级:0级9例、1级8例、2级21例、3级14例;选取28例健康体检者为对照组。分析MIP-1α、骨硬化蛋白与MBD的关系。结果观察组MIP-1α及骨硬化蛋白分别为(158.43±78.75)pg/mL、(0.62±0.24)pg/mL,均明显高于对照组的(52.46±21.35)pg/mL、(0.31±0.14)pg/mL(t=9.635,P<0.05;t=8.844,P<0.05);MIP-1α、骨硬化蛋白随临床分期增加而逐渐升高(P<0.05);有骨病组MIP-1α及骨硬化蛋白分别为(175.55±62.75)pg/mL、(0.84±0.54)pg/mL,明显高于无骨病组的(89.83±41.57)pg/mL、(0.42±0.25)pg/mL(t=7.665,P<0.05;t=6.834,P<0.05);MIP-1α和骨硬化蛋白与骨病分级存在相关性(r=0.572,P<0.05;r=0.683,P<0.05)。MIP-1α与骨硬化蛋白呈正相关(r=0.522,P<0.05)。结论 MM患者MIP-1α及骨硬化蛋白水平明显升高,两者均与MBD呈正相关,且两者之间也具有明显相关性,联合检测可作为评估MBD的重要指标。
目的:研究巨噬細胞炎癥蛋白-1α( MIP-1α)、骨硬化蛋白與多髮性骨髓瘤( MM)併髮骨髓瘤骨病( MBD)的關繫。方法以52例MM患者為觀察組,其中無骨病者9例,有骨病者43例;MBD分級:0級9例、1級8例、2級21例、3級14例;選取28例健康體檢者為對照組。分析MIP-1α、骨硬化蛋白與MBD的關繫。結果觀察組MIP-1α及骨硬化蛋白分彆為(158.43±78.75)pg/mL、(0.62±0.24)pg/mL,均明顯高于對照組的(52.46±21.35)pg/mL、(0.31±0.14)pg/mL(t=9.635,P<0.05;t=8.844,P<0.05);MIP-1α、骨硬化蛋白隨臨床分期增加而逐漸升高(P<0.05);有骨病組MIP-1α及骨硬化蛋白分彆為(175.55±62.75)pg/mL、(0.84±0.54)pg/mL,明顯高于無骨病組的(89.83±41.57)pg/mL、(0.42±0.25)pg/mL(t=7.665,P<0.05;t=6.834,P<0.05);MIP-1α和骨硬化蛋白與骨病分級存在相關性(r=0.572,P<0.05;r=0.683,P<0.05)。MIP-1α與骨硬化蛋白呈正相關(r=0.522,P<0.05)。結論 MM患者MIP-1α及骨硬化蛋白水平明顯升高,兩者均與MBD呈正相關,且兩者之間也具有明顯相關性,聯閤檢測可作為評估MBD的重要指標。
목적:연구거서세포염증단백-1α( MIP-1α)、골경화단백여다발성골수류( MM)병발골수류골병( MBD)적관계。방법이52례MM환자위관찰조,기중무골병자9례,유골병자43례;MBD분급:0급9례、1급8례、2급21례、3급14례;선취28례건강체검자위대조조。분석MIP-1α、골경화단백여MBD적관계。결과관찰조MIP-1α급골경화단백분별위(158.43±78.75)pg/mL、(0.62±0.24)pg/mL,균명현고우대조조적(52.46±21.35)pg/mL、(0.31±0.14)pg/mL(t=9.635,P<0.05;t=8.844,P<0.05);MIP-1α、골경화단백수림상분기증가이축점승고(P<0.05);유골병조MIP-1α급골경화단백분별위(175.55±62.75)pg/mL、(0.84±0.54)pg/mL,명현고우무골병조적(89.83±41.57)pg/mL、(0.42±0.25)pg/mL(t=7.665,P<0.05;t=6.834,P<0.05);MIP-1α화골경화단백여골병분급존재상관성(r=0.572,P<0.05;r=0.683,P<0.05)。MIP-1α여골경화단백정정상관(r=0.522,P<0.05)。결론 MM환자MIP-1α급골경화단백수평명현승고,량자균여MBD정정상관,차량자지간야구유명현상관성,연합검측가작위평고MBD적중요지표。
Objective To investigate the relationship between macrophage inflammatory protein 1-α( MIP-1α) ,sclerostin and multiple myeloma bone disease( MBD) .Methods 52 patients with multiple myeloma were selected as the observation group,among them,9 cases without MBD,43 cases with MBD;MBD grade:9 cases with grade 0,8 cases with grade 1,21 cases with grade 2,14 cases with grade 3.25 healthy examinee were selected as the control group.MIP-1αand sclerostin were observed.Results MIP-1α,sclerostin in the observation group[(158.43 ± 78.75)pg/mL,(0.62 ±0.24)pg/mL] were higher than those in the control group[(52.46 ±21.35)pg/mL,(0.31 ± 0.14)pg/mL](t =9.635,P <0.05;t =8.844,P <0.05);MIP-1α,sclerostin of MBD patients[(175.55 ± 62.75)pg/mL,(0.84 ±0.54)pg/mL]were higher than those of non MBD patients[(89.83 ±41.57)pg/mL,(0.42 ± 0.25)pg/mL](t=7.665,P<0.05;t=6.834,P<0.05).There were positive relation between MIP-1α,sclerostin and the grade of MBD(r=0.572,P<0.05;r=0.683,P<0.05).There was positive relation between the expressions of MIP-1αand sclerostin(r =0.522,P <0.05).Conclusion MIP-1αand sclerostin of patients with MM have increased.There is a significant relation between MIP-1α, sclerostin and MBD.United detection of MIP-1αand sclerostin may be an index used as evaluation of MBD.